Congenital lactic acidosis.
For use in screening for disorders of pyruvate metabolism in cultured skin fibroblasts, we developed a sensitive assay method for measuring the rates of decarboxylation of (1-14C)-pyruvate using dichloroacetate (DCA). By this method, disorders of the mechanism of activation of pyruvate dehydrogenase (PDH) were found in 2 of 10 patients with congenital lactic acidosis of unknown cause. We also found that DCA activated the PDH complex and the tricarboxylic acid cycle, which is an important pathway of energy metabolism, in the brain and other tissues, and lowered the lactate level in the blood and cerebrospinal fluid. Therefore, DCA therapy may be useful in treatment of chronic congenital lactic acidosis if this treatment is started sufficiently early.
Department of Pediatrics, School of Medicine, University of Tokushima, Japan.
Y
Y
Kuroda
E
E
Naito
E
E
Takeda
I
I
Yokota
M
M
Miyao
D000085:Acetates / Q000627:therapeutic use*; D000140:Acidosis, Lactic / Q000151:congenital / Q000188:drug therapy* / Q000378:metabolism; D000293:Adolescent; D003653:Decarboxylation; D003999:Dichloroacetic Acid / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D007773:Lactates / Q000378:metabolism*; D008297:Male; D011773:Pyruvates / Q000378:metabolism*
D000085:Acetates; D007773:Lactates; D011773:Pyruvates; D003999:Dichloroacetic Acid